Ali Zamir Khan
Medanta, the Medicity, Delhi NCR, India
MBBS, MS, FRCS (Glasgow), FRCS (CTH), FEBTS, MBA
Fellowship Sports Med (RCSI, Ireland), PGDM (Clinical Research, UK), CCT (UK)
Dr. Ali Zamir Khan has started the Robotic Thoracic Surgery Programme in India at Medanta, The Medicity. He has performed India’s First Robotic Upper Lobectomy for Cancer and Middle Lobectomy for Cancer of the Lung. In addition, he has performed Robotic Thymectomy for Myaesthenia gravis and thymic cancer, Robotic resection of anterior and posterior mediastinal Tumours, Robotic Resection of Thoracic Outlet tumour, Robotic resection of Lung metastases, Robotic resection of nerve Tumors (Schwannoma). This wide range of surgery is unique to Medanta, The Medicity. The Team is the only centre in Asia which is capable of performing such complex surgeries.
Dr. Khan is also an expert in Video Assisted Thoracoscopic Surgery and Open Thoracic Surgery (98 % of all his work is performed through minimally invasive techniques). The benefit of minimally invasive surgery to the patient is immense in terms of less pain, shorter hospital stay, quicker recovery, and faster returns to work.
Dr. Khan brings in a rich excellent work experience in the field of Minimally Invasive Thoracic Surgery. He completed his training in General Surgery at KEM Hospital, Mumbai and thereafter trained in cardiothoracic surgery under Prof. Sir Magdi Yacoub and Prof. Robert Bonser at two of the world’s most renowned centres in Harefield Hospital and Queen Elizabeth Hospital (University of Birmingham and University of Middlesex). Before joining Medanta, Dr. Khan was attached to Southampton University Hospital as a Consultant Surgeon where his team performed one of the highest numbers of VATS Lobectomies in the UK. He has worked in the United Kingdom for about 20 years before deciding to return to India.
Having a strong interest in academics and research, Dr. Khan has published a widely acclaimed research thesis on “Immune responses during cardiopulmonary bypass” in collaboration with Oxford University. In addition, he is involved in pioneering research in Flow Cytometry and analysis of biological nature of lung cancer at the Southampton University Hospital. He is currently working on development of a porcine model for Endobronchial Lobectomy and Natural Orifice Thoracic Surgery. Overall, he has published more than 100 original research papers and chapters, and delivered more than 50 invited lectures all over the world in his field.
Dr. Khan has received numerous awards and honors for his contribution in academic excellence. Last year he was awarded the President’s award for best international research paper in Thoracic Surgery at the Meeting of The International Society of Minimally Invasive Cardiothoracic Surgery at San Francisco. His team repeated the performance by bagging the award for the best research paper at the winter meeting of ISMICS held at New Delhi. He has been the Course Director for VATS Wetlab organized by the European Association of Cardiovascular Surgeons, Turkish Society of Cardiothoracic Surgeons, Tunisian Society of Respiratory Medicine and Surgery and a faculty on the Covidien and Ethicon VATS Course and other international conferences in UK, US, and Middle East. He is also faculty on many international conferences in Minimally Invasive Thoracic Surgery.